haemophilusinfluenzae
TRANSCRIPT
![Page 1: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/1.jpg)
HaemophilHaemophilus & us &
BordetellaBordetella
A. L. Samer FaisalA. L. Samer Faisal
![Page 2: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/2.jpg)
Haemophilus influenzaeHaemophilus influenzae Gram negative Rods.Gram negative Rods. Range from coccobacillary to long Range from coccobacillary to long
filamentous forms.filamentous forms. Non – motileNon – motile Aerobic Aerobic Fastidious organismsFastidious organisms
![Page 3: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/3.jpg)
Haemophilus influenzaeHaemophilus influenzae Humans are the only natural hostsHumans are the only natural hosts
Transmission:Transmission: respiratory droplet spread respiratory droplet spread
Peak Prevalence of Meningitis: Peak Prevalence of Meningitis: 6 – 12 6 – 12 monthsmonths
The incidence of Hib fell by 95% in The incidence of Hib fell by 95% in populations with high rates of vaccinationpopulations with high rates of vaccination
![Page 4: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/4.jpg)
Haemophilus influenzaeHaemophilus influenzaeTwo main typesTwo main types::
II The uncapsulated (untypable) The uncapsulated (untypable) strainsstrains
IIII The encapsulated strainsThe encapsulated strains
![Page 5: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/5.jpg)
CapsuleCapsule Polysaccharide in naturePolysaccharide in nature
Six types : a, b, c, d, e and fSix types : a, b, c, d, e and f
Type b is associated with most severe Type b is associated with most severe form of disease form of disease
Hib capsule is Polyribitol Phosphate (PRP)Hib capsule is Polyribitol Phosphate (PRP)
![Page 6: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/6.jpg)
Haemophilus influenzaeHaemophilus influenzaeUnencapsulatedUnencapsulated
Responsible for Responsible for localized infections localized infections i.e.i.e.
Otitis mediaOtitis media ConjuctivitisConjuctivitis BronchitisBronchitis SinusitisSinusitis
CapsulatedCapsulated Responsible for Responsible for Invasive disease Invasive disease i.e.i.e.
MeningitisMeningitis SepticaemiaSepticaemia EpiglottitisEpiglottitis PneumoniaPneumonia Septic arthritisSeptic arthritis CellulitisCellulitis
![Page 7: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/7.jpg)
LABORATORY LABORATORY DIAGNOSISDIAGNOSIS
Clinical SpecimensClinical Specimens Blood, sputum, CSF, Joint fluidBlood, sputum, CSF, Joint fluid
MicroscopyMicroscopy Gram StainGram Stain Flourescent antibody stainFlourescent antibody stain
CultureCulture Chocolate Agar (Factor V & X)Chocolate Agar (Factor V & X)
SerologySerology Latex agglutination, Counter Latex agglutination, Counter
immunoelectrophoresisimmunoelectrophoresis PCRPCR
![Page 8: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/8.jpg)
![Page 9: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/9.jpg)
Growth requirements in Growth requirements in VitroVitro
Factor Factor VV HeminHemin
FactorFactor XX NADNAD
Chocolate agar provide both these Chocolate agar provide both these factorsfactors
Growth is enhanced in 5% CoGrowth is enhanced in 5% Co2 2
![Page 10: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/10.jpg)
![Page 11: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/11.jpg)
TREATMENTTREATMENT Meningitis – CeftriaxoneMeningitis – Ceftriaxone Otitis media & Sinusistis – Amoxycillin-Otitis media & Sinusistis – Amoxycillin-
clavulanate & Co-trimoxazoleclavulanate & Co-trimoxazole
PREVENTIONPREVENTION Vaccine against hemophilus type-b (Hib)Vaccine against hemophilus type-b (Hib)
Age 2-15 monthsAge 2-15 months Conjugate vaccineConjugate vaccine
RifampicinRifampicin
![Page 12: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/12.jpg)
Haemophilus ducreyiHaemophilus ducreyi
Causes a sexually transmitted Causes a sexually transmitted infection called Chancroidinfection called Chancroid
Requires only Factor X for growthRequires only Factor X for growth
![Page 13: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/13.jpg)
Bordetella pertussisBordetella pertussis Small Coccobacillary Small Coccobacillary Gram negative rodGram negative rod CapsulatedCapsulated Causes Pertussis (Whooping Cough) Causes Pertussis (Whooping Cough)
– a highly infectious disease in its – a highly infectious disease in its early phaseearly phase
![Page 14: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/14.jpg)
Bordetella pertussisBordetella pertussis Pathogen only for humansPathogen only for humans Transmitted by airborne dropletsTransmitted by airborne droplets Highly contagiousHighly contagious Worldwide distributionWorldwide distribution Primarily infants & young childrenPrimarily infants & young children
![Page 15: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/15.jpg)
• Typical OrganismsThe organisms are minute, gram-negative
coccobacilli resembling H influenzae. A capsule is present.
• Culture Primary isolation of B pertussis requires
enriched media. Bordet-Gengou medium (potato-blood-glycerol
agar) that contains penicillin G, 0.5 μg/mL, can be used.
A charcoal-containing medium supplemented with horse blood, cephalexin, and amphotericin B (Regan-Lowe) is preferable because of the longer shelf life.
The plates are incubated at 35–37°C for 3–7 days aerobically in a moist environment.
The small, faintly staining gram negative rods are identified by immunofluorescence staining.
B pertussis is non-motile.
![Page 16: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/16.jpg)
• Growth Characteristics
The organism is a strict aerobe. it is oxidase and catalase positive. but nitrate, citrate, and urea
negative, the results of which are useful for differentiating among the other species of bordetellae.
It does not require X and V factors on subculture.
![Page 17: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/17.jpg)
CLINICAL FEATURESCLINICAL FEATURES Acute tracheobronchitis in Acute tracheobronchitis in
childrenchildren Mild upper respiratory tract symptomsMild upper respiratory tract symptoms Severe paroxysmal cough (1 to 4 weeks)Severe paroxysmal cough (1 to 4 weeks) Death due to pneumoniaDeath due to pneumonia
In AdultsIn Adults Paroxysmal cough lasting weeks (100 day Paroxysmal cough lasting weeks (100 day
cough)cough) Whoop is absentWhoop is absent
![Page 18: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/18.jpg)
Laboratory DiagnosisLaboratory Diagnosis Clinical SpecimensClinical Specimens
Nasopharyngeal swabNasopharyngeal swab MicroscopyMicroscopy
Gram negative rodsGram negative rods Flourescent antibody stainingFlourescent antibody staining
CultureCulture Bordet gengou medium (20-30% blood)Bordet gengou medium (20-30% blood)
SerologySerology Agglutination with specific antiseraAgglutination with specific antisera
PCRPCR
![Page 19: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/19.jpg)
TREATMENTTREATMENT AntibioticAntibiotic
ErythromycinErythromycin Supportive CareSupportive Care
Oxygen TherapyOxygen Therapy Suction of mucusSuction of mucus
![Page 20: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/20.jpg)
PREVENTIONPREVENTION VaccinesVaccines
Acellular pertussis vaccineAcellular pertussis vaccine BoostrixBoostrix AdacelAdacel
Killed Vaccine Killed Vaccine Higher side effects (encephalopathy)Higher side effects (encephalopathy)
AntibioticsAntibiotics ErythromycinErythromycin
Un-immunized & exposedUn-immunized & exposed Immunized & < 4 yrs.Immunized & < 4 yrs.
![Page 21: Haemophilusinfluenzae](https://reader035.vdocuments.us/reader035/viewer/2022070517/58ceb00f1a28abb2218b4ceb/html5/thumbnails/21.jpg)
QUESTIONS...???QUESTIONS...???